Biotechnology
Cellenkos(R) Inc. Announces FDA Clearance to Initiate Phase 1 Double- Blinded, Randomized, Placebo-Controlled Trial of Cryopreserved Cord Blood-Derived T-Regulatory Cells (CK0802) for Treatment of COVID-19 Associated Acute Respiratory Distress Syndrome
HOUSTON, June 2, 2020 /PRNewswire/ -- Cellenkos Inc., a privately held, clinical stage biotech company announced today that the US Food & Drug Administration (FDA) has cleared the way to initiate a Phase 1 clinical trial of CK0802 (Cryopreserved Cord Blood Derived T-Regulatory Cells) for treatmen...
2020-06-02 18:00
1756
Innovent Announced the Preliminary Results of the Anti-PD-1/PD-L1 Bispecific Antibody IBI318 in a Phase 1 Clinical Study
SUZHOU, China, June 2, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, announced the ...
2020-06-02 07:30
6136
AGC Biologics Acquires Commercial Facility, Expanding Global Service Offerings
AGC Biologics acquires Boulder, Colorado U.S.A. facility to increase global capacity and extend manufacturing scale SEATTLE, June 2, 2020 /PRNewswire/ -- AGC Biologics, a global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced the purchase of a state-of-the...
2020-06-02 06:00
3333
Kazia Presents Interim Paxalisib Phase II Data at ASCO Showing Positive Overall Survival Signal
SYDNEY, June 1, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to share a poster presentation of interim data from the ongoing phase II study of paxalisib (formerly GDC-0084) in glioblastoma, the most comm...
2020-06-01 08:45
5116
Innovent Biologics Announced the Long-Term Follow-Up Results of TYVYT® (Sintilimab Injection) in the Treatment of Relapsed or Refractory Extranodal NK/T-Cell Lymphoma (Nasal Type)
SUZHOU, China, June 1, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, announced ...
2020-06-01 07:30
5163
Innovent Biologics and Lilly Jointly Announced the Long-Term Follow-Up Results of TYVYT® (Sintilimab Injection) in the Treatment of Patients with Relapsed/Refractory Classic Hodgkin's Lymphoma
SUZHOU, China, June 1, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines, jointly announced with Eli Lilly and Company (Lilly) (NYSE: LLY) the research results of TY...
2020-06-01 07:30
5274
Innovent Biologics and Lilly Jointly Announced the Pivotal Clinical Study Results of TYVYT® (Sintilimab Injection) in the Second-Line Treatment of Patients with Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma
SUZHOU, China, June 1, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines, jointly announced with Eli Lilly and Company (Lilly) (NYSE: LLY) the results of TYVYT® (sin...
2020-06-01 07:30
5477
Innovent Biologics Announced the Results of the Phase 1b Clinical Study of TYVYT® (Sintilimab Injection) in Combination with IBI305 (Bevacizumab Biosimilar) in the Treatment of Advanced Hepatocellular Carcinoma
SUZHOU, China, June 1, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, announce...
2020-06-01 07:30
5181
Guardant360 test results may provide prognostic information beyond the detection of actionable biomarkers for ALK-rearranged NSCLC patients
SINGAPORE, May 30, 2020 /PRNewswire/ -- According to the data presented at the American Society of Clinical Oncology (ASCO) Annual Meeting on29 May 2020, researchers at Samsung Medical Center inSeoul, Korea, have found useful prognostic information beyond actionable biomarkers when the Guardant36...
2020-05-30 19:00
3378
Shinshu University and Toshiba Develop Tumor-Tropic Liposome Technology that Carries Therapeutic Genes into Cancer Cells
TOKYO, May 28, 2020 /PRNewswire/ -- Toshiba Corporation (TOKYO: 6502, hereinafter "Toshiba") and a team led by ProfessorYozo Nakazawa at the Department of Pediatrics, Shinshu University, (hereinafter "Shinshu University"), have together developed a "tumor-tropic liposome technology" for gene the...
2020-05-28 23:00
7821
CordenPharma & Moderna Extend Strategic Manufacturing Services Agreement for the Supply of Lipid Excipients to be used in Moderna's Vaccine (mRNA-1273) Against the Novel Coronavirus SARS-CoV-2
LUXEMBOURG, May 28, 2020 /PRNewswire/ -- CordenPharma, a full-service Contract Development & Manufacturing Organization (CDMO) for the supply of APIs, Drug Products & Pharmaceutical Packaging, announces the signing of an amendment to their existing manufacturing agreement withModerna, Inc. (Nasda...
2020-05-28 13:30
5805
WuXi Biologics Sweeps 2020 CMO Leadership Awards in All Six Categories
SHANGHAI and NEW YORK, May 28, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has been recognized by Life Science Leader for the third year, achieving 2020 CMO Leadership Awards in six criter...
2020-05-28 08:00
2467
Ajinomoto Bio-Pharma Services Signs Manufacturing Agreement with Humanigen for Lenzilumab, Currently in FDA-Approved Phase III Study for COVID-19
SAN DIEGO, May 27, 2020 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce it has entered into a manufacturing agreement with Humanigen, Inc., for the fill finish supply ...
2020-05-27 20:07
2328
Jennewein Publishes New Results on the Norovirus-inhibiting Effect of Complex Oligosaccharides
RHEINBREITBACH, Germany, May 27, 2020 /PRNewswire/ -- Jennewein Biotechnologie GmbH today announces the publication of the latest results from its norovirus research program in theJournal of Biotechnology. Breast-fed infants are less likely than bottle-fed infants to contract norovirus infecti...
2020-05-27 19:22
3043
Daewoong Pharmaceutical Acquires Halal Certification for 'Easyef' through Daewoong Infion
SEOUL, South Korea and JAKARTA, Indonesia, May 27, 2020 /PRNewswire/ -- Daewoong Pharmaceutical (CEOSengho Jeon) announced on May 25 that the Indonesian joint venture Daewoong Infion (CEOChang Woo Suh) obtained Halal certification for the diabetic foot ulcer drug 'Easyef topical solution(Easyef)...
2020-05-27 10:00
4397
Innovent Announces First Patient Dosed in A Phase 1 Clinical Trial of Anti-TIGIT Monoclonal Antibody in China
SUZHOU, China, May 26, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, today anno...
2020-05-26 07:30
9434
HistoIndex's AI-based Digital Pathology Platform: A Validated Quantification Tool Recommended in the Guidelines for the Prevention and Treatment of Chronic Hepatitis B in China
SINGAPORE, May 25, 2020 /PRNewswire/ -- Singapore medtech company HistoIndex
2020-05-25 06:00
3416
Takara Bio Selects AGC Biologics as Manufacturer of Plasmid DNA Intermediate for a Vaccine Against COVID-19 (SARS-CoV-2)
SEATTLE, May 21, 2020 /PRNewswire/ -- AGC Biologics, a global Contract Development and Manufacturing Organization (CDMO) for Biopharmaceuticals, has announced its partnership withTakara Bio.The companies will partner in the fight against COVID-19 by collaborating on a prophylaxis DNA vaccine, wit...
2020-05-21 14:00
3647
Catalent Announces Acquisition of Japanese Facility to Provide Local and Global Clinical Supply Solutions
SOMERSET, N.J., May 21, 2020 /PRNewswire/ -- Catalent (NYSE:CTLT), a global leader in clinical supply services, today announced a deal to acquire a clinical packaging facility in Minakuchi, located in the Shiga prefecture of Japan, from Teva-Takeda Pharmaceuticals, Nagoya Aichi, Japan. This purcha...
2020-05-21 12:00
14362
VeChain and I-Dante Co-developed E-HCert, A Blockchain-based COVID-19 Records App For the Citizens of Cyprus
SHANGHAI, May 20, 2020 /PRNewswire/ -- With the pandemic putting healthcare systems under strain worldwide, Electronic Health Record (EHR) systems are also shifting requirements for data security and sharing. As the leading public blockchain platform, VeChain furthers the collaboration with I-Dan...
2020-05-20 23:00
6495
Week's Top Stories
Most Reposted
Going Global: DCITS Embarks on International Expansion at Singapore Fintech Festival
[Picked up by 313 media titles]
2024-11-12 09:00
DKSH Healthcare and Euris Unveil CRM & MCE Platform "ConnectPlus" to Revolutionize APAC Healthcare Distribution
[Picked up by 293 media titles]
2024-11-13 09:00
Sobot Introduces its All-in-One Solution at GITEX Global 2024
[Picked up by 291 media titles]
2024-11-12 11:00
Ubiqconn Technology to Showcase Latest Marine Solutions at the 2024 International WorkBoat Show in New Orleans
[Picked up by 289 media titles]
2024-11-11 21:00
DND International Eye Hospital: Pioneering SMILE Pro Surgery & Leading the Trend of Refractive Surgery Tourism in Vietnam
[Picked up by 279 media titles]
2024-11-08 20:11
Most Read
Ubiqconn Technology to Showcase Latest Marine Solutions at the 2024 International WorkBoat Show in New Orleans
2024-11-11 21:00
5634
DND International Eye Hospital: Pioneering SMILE Pro Surgery & Leading the Trend of Refractive Surgery Tourism in Vietnam
2024-11-08 20:11
5568
HOIANA RESORT & GOLF LAUNCHES PREMIUM HOIANA PICKLEBALL COURT
2024-11-08 00:18
5520
Going Global: DCITS Embarks on International Expansion at Singapore Fintech Festival
2024-11-12 09:00
5403